Long-term follow up data from the Phase 1 study of pevifoscorvir sodium continues to suggest a reduction in the cccDNA reservoirData on the ...
VectorBuilder, a global leader in gene delivery technologies, today announced plans to invest $50 million to establish a new Advanced Biomanufacturing and R&D Center in Chicago, marking a major ...
The wet AMD market is expected to grow due to the increasing diagnosed cases of Wet-AMD, the current therapies, and the launch of emerging therapies such as Ixoberogene soroparvovec (Ixo-vec) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results